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Regional Implementation of a Pediatric Cardiology Syncope Algorithm
Using Standardized Clinical Assessment and Management Plans
(SCAMPS) Methodology
Yvonne Paris, MD; Olga H. Toro-Salazar, MD; Naomi S. Gauthier, MD; Kathleen M. Rotondo, MD; Lucy Arnold, MD;
Rose Hamershock, MA; David E. Saudek, MD; David R. Fulton, MD; Ashley Renaud, RN; Mark E. Alexander, MD;
on behalf of the New England Congenital Cardiology Association (NECCA)*
Background-—Pediatric syncope is common. Cardiac causes are rarely found. We describe and assess a pragmatic approach to
these patients first seen by a pediatric cardiologist in the New England region, using Standardized Clinical Assessment and
Management Plans (SCAMPs).
Methods and Results-—Ambulatory patients aged 7 to 21 years initially seen for syncope at participating New England
Congenital Cardiology Association practices over a 2.5-year period were evaluated using a SCAMP. Findings were iteratively
analyzed and the care pathway was revised. The vast majority (85%) of the 1254 patients had typical syncope. A minority had
exercise-related or more problematic symptoms. Guideline-defined testing identified one patient with cardiac syncope. Syncope
Severity Scores correlated well between physician and patient perceived symptoms. Orthostatic vital signs were of limited use.
Largely incidental findings were seen in 10% of ECGs and 11% of echocardiograms. The 10% returning for follow-up, by design,
reported more significant symptoms, but did not have newly recognized cardiac disease. Iterative analysis helped refine the
approach.
Conclusions-—SCAMP methodology confirmed that the vast majority of children referred to the outpatient pediatric cardiology
setting had typical low-severity neurally mediated syncope that could be effectively evaluated in a single visit using minimal
resources. A simple scoring system can help triage patients into treatment categories. Prespecified criteria permitted the effective
diagnosis of the single patient with a clear cardiac etiology. Patients with higher syncope scores still have a very low risk of cardiac
disease, but may warrant attention. ( J Am Heart Assoc. 2016;5:e002931 doi: 10.1161/JAHA.115.002931)
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N eurally mediated syncope—an abrupt, reflex-mediatedtransient loss of consciousness—is very common with
a cumulative incidence of 35% by age 18 and nearly 50% by
age 21.1 Newly recognized cardiac disease is rare. While not
all pediatric patients with syncope come to medical attention,
the mismatch of an exceptionally common cardinal symptom
and a rare but potentially life-threatening cause motivates
frequent referral and cardiac evaluation.
The evaluation of these patients can be extensive,
expending considerable time and resources.2–4 Previous
reports on syncope have been mostly observational.4–6 To
address this, a group of pediatric cardiologists from around
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ORIGINAL RESEARCH
New England collaborated to design and implement a quality
improvement tool utilizing Standardized Clinical Assessment
and Management Plans (SCAMPs) to guide the care of
patients presenting to a pediatric cardiology outpatient clinic
with a complaint of syncope. SCAMPs methodology uses
prospective acquisition of defined data that are analyzed on a
recurring basis. A sound initial approach is combined with
specific, testable, targeted data statements about either
diagnostic or therapeutic approaches. Changes to the care
pathways are based on this analysis.7,8
New England Congenital Cardiology Association (NECCA),
an organization of 16 academic and community-based
practices representing all 6 New England states, previously
successfully implemented a SCAMP on chest pain resulting in
a decrease in practice variation and resource utilization.7,9,10
The syncope SCAMP objective was to develop a standard-
ized approach to evaluation of syncope in the outpatient
setting. The pathway which emphasized the critical aspects of
history, focused family history, physical exam, orthostatic vital
signs, and an ECG was asserted to have a high negative
predictive value. This would allow identification of the smaller
number of patients with higher probability of significant
cardiac disease or inherited arrhythmia syndromes and limit
the more complex testing. Once the cause of syncope was
identified, specific approaches to management were outlined
with an emphasis on education and nonpharmacologic
management for patients with typical syncope.
Methods
We developed a SCAMP clinical care pathway for syncope
using history, physical examination, and ECG.11,12 This
evaluation targeted pediatric, adolescent, and young adult
patients 7 to 21 years of age who present to pediatric
cardiology outpatient practices for a chief complaint of
syncope. The SCAMP was designed to explore multiple
questions simultaneously by targeted data statements. These
formed the basis for the clinical care pathway and SCAMP
Data Form (SDF) used to track the SCAMP. The strategies for
implementation were shared and the guideline was revised
based on feedback. Flexibility in implementation of the
SCAMP was necessary due to the variation of resources
available at different sites. Specific pathways were outlined
for typical, exertional, convulsive, atypical/refractory syn-
cope, and postural tachycardia syndrome (POTS)
(Appendix S1).
This care pathway was specifically designed to classify the
type of syncope and to identify cardiac causes of syncope
using the resources in the outpatient cardiology clinical
setting. The intent was to complete the evaluation in a single
visit for patients with typical, low-severity syncope.
The institutional review boards at Boston Children’s
Hospital and the participating NECCA sites evaluated the
project and waived review designating the SCAMP method-
ology as a quality improvement initiative. Data use agree-
ments limited reporting age/sex from NECCA sites.
All patient data were de-identified. Activity at the NECCA
sites was facilitated, tracked, and coordinated through
monthly conference calls that ensured uniformity in use of
the SCAMP. Following a pilot period, minor revisions were
made and the SCAMP was deployed throughout NECCA for
15 months followed by data analysis and revision of the
process with continued tracking for 18 months. Practices
entered the SCAMP at different times, so that not all practices
were involved the entire 33 months.
There were 2 phases of analysis. Phase 1 used the initial
clinical pathways with interim analyses that motivated
modification to the revised Phase 2 pathway. Phase 1
analysis included patients enrolled between March 2012
and July 2013, with Phase 2 analysis representing patients
entered between August 2013 and December 2014. Interim
analyses were also performed. Each analysis was presented
broadly within NECCA for feedback followed by modification
of the algorithm by consensus.
Patient Selection
Ambulatory patients between 7 and 21 years of age present-
ing to an outpatient pediatric cardiology practice for a first-
time evaluation of the principal complaint of syncope were
enrolled. A complete history and physical exam were
performed and an ECG was reviewed.
Patients were excluded for cardiac arrest needing sustained
cardiopulmonary resuscitation, previously diagnosed seizure,
or known cardiac disease. Those with WPW (Wolff Parkinson
White) or QT interval >480 ms (Long QT Syndrome) on initial
ECG were also excluded. The SDF did not track exclusions.
Data Collection
Clinical evaluation and classifications
Based on initial history and exam, each patient was classified as
having typical, exertional, convulsive, atypical/refractory syn-
cope, or POTS. Clinical workflow was completely at the
clinician’s discretion, such that echocardiogramor other testing
could be scheduled prior to the history and physical.
Demographics and clinical characteristics were collected
including signs, symptoms and consequences of the synco-
pal event as well as pertinent past medical and family
history. Historical data were also noted with regard to past
evaluations for syncope and previous specialist or emer-
gency room evaluation. Pertinent physical exam findings,
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ECG interpretation, and orthostatic vital signs were recorded
either manually or using automated equipment. Orthostatic
blood pressure measurements were discontinued during
Phase 2 based on analysis of Phase 1 data. The patient
judged their symptom severity using 2 subjective, 10-point
syncope scales for daily dizziness and overall well-being/
wellness. The provider assessed a 0 to 12 point Syncope
Severity Score (SSS) based on frequency, severity, and
disability associated with the symptoms (Appendix S2).
The initial ECG was evaluated and any abnormalities were
noted. Pertinent abnormalities were tabulated, but specific
criteria for each ECG diagnosis were neither mandated nor
independently reviewed. Echocardiograms were recom-
mended for predefined, generally accepted consensus-based
criteria focusing on exertional symptoms or concerning
features of the presentation (abrupt onset, injury), abnormal
ECG or examination, and potentially concerning family history.
Echocardiograms done for family/clinician anxiety were
tracked. Patients defined as having typical low-severity
syncope were provided with teaching materials and reassur-
ance and not scheduled for follow-up. A complete blood count
and ferritin level were recommended for those defined with
moderate to severe typical syncope.13,14 Provider preference
regarding medical treatment or conservative management
was recorded, and patient follow-up in 2 months to review
response to treatment was recommended.
If patients reported a syncopal event with or immediately
following exercise, they were classified as having exertional
syncope. Echocardiograms were recommended for those
patients who were noted to have syncope during exercise. If
no abnormalities were noted on the echocardiogram, then
treadmill exercise testing was recommended. Patients exited
the SCAMP care pathway if either a structural abnormality or
a clinically important arrhythmia were identified. Otherwise,
management mirrored typical syncope.
Syncope was classified as convulsive if the patient was
noted to stiffen or have brief tonic–clonic movements during
the event. Repeated episodes, sustained tonic–clonic events,
or neurological findings dictated neurology referral. Repeated
episodes directed an exercise test and an echocardiogram as
well as ambulatory arrhythmia testing with a loop recorder if
the frequency of convulsive syncope was greater than twice a
month.
POTS was initially defined as a change in heart rate (HR) of
>30 beats per minute during the orthostatic testing process
delineated in the SCAMP care pathway with plausible
symptoms.15 Atypical syncope was defined as SSS >8 with
combinations of disabling symptoms, syncope while supine,
delayed recovery, or sustained “jerking/stiffening” combined
with frequent events. More expansive laboratory screening
and monitoring was recommended with SSS >4 with partic-
ular focus on those with SSS ≥8.
Treatment with iron was suggested if ferritin levels were
<50 ng/mL. Patients with endocrinopathies were referred
and exited the SCAMP. Provider preference regarding medical
treatment or conservative management was recorded.
Patients were recommended for follow-up in 2 months to
review response to treatment if the patient had moderate or
more severe syncope.
Test interpretation
ECG and ancillary testing interpretations were tabulated
based on results recorded on the SDFs. Testing was generally
obtained at the time of the initial visit or soon after. Test
results performed prior to the pediatric cardiology visit were
also noted. There was no attempt to validate results.
Ambiguity on critical data was resolved by querying the
submitting clinical site.
SCAMP data collection and analysis
Data were collected on an SDF completed by the provider at
the initial visit (Appendix S2). Patients who had scheduled
follow-up or who returned after discharge from the clinic were
evaluated using a second SDF documenting interval history
self-reports/assigned SSS. Data were collated by the Institute
for Relevant Clinical Data Analytics for NECCA and operations
staff at Boston Children’s Hospital.
Results of testing were tracked to assess adherence to the
recommendations of the algorithm and to analyze outcomes.
Statistical Analysis
Summary statistics were tabulated. Differences in patient and
family history by site and syncope type were examined with
v2 and Fisher exact tests. Chi-square and Fisher exact tests
were also used to analyze the difference in ECG results over
syncope types. Bubble plots and correlation analysis were
performed on the relationship between physician-assigned
and patient-assessment scores. Logistic regression analyzed
differential medication use. Lastly, the receiver operating
characteristic c-statistic was calculated to determine whether
the differences in orthostatic supine values and 3-minute
standing orthostatic values were useful in determining
syncope classifications. With the exception of specific anal-
yses of follow-up, all analyses were performed on the initial
episode of care to maintain independence.
Results
Patient Population
Between March of 2012 and December of 2014 a total of
1292 patients (1437 total visits) were enrolled with 91%
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having a single visit. Of those initial visits, 38 were poorly
characterized and excluded. Of the remaining 1254 patients,
1063 (85%) were classified as having typical syncope with the
remaining 191 (15%) being classified as atypical/refractory
43 (3%), exertional 77 (6%), convulsive 39 (3%), or POTS 32
(3%) (Figure 1). Of the 1254 initial visits, 836 or (67%) were
evaluated at Boston Children’s Hospital and the remaining
418 were seen at NECCA sites. The distribution between sites
was comparable (v2 P=0.08).
For the Boston Children’s Hospital cohort, 63% were
female with 462 (88%) of the females classified as having
typical syncope compared to 83% of the males (Table 1). The
average age was 14.53 years with age-expected heights
and weights associated with a mean body mass index of
214. There was a trend toward proportionally more males
with syncope not classified as typical, though this did not
reach significance. Because typical syncope was diagnosed in
the vast majority of patients, this category became the
primary focus of subsequent analysis.
Initial Evaluation
History and physical exam
Historical details are outlined in Table 2, which represents
positive responses to the questions. Over 80% had dizziness
or lightheadedness and experienced a prodrome. Typically 2%
to 5% of all questions had missing data.
By design, the exercise questions selected patients with
exertional syncope, but otherwise responses did not vary with
syncope type. The questions did not effectively capture
triggering events other than exercise. Notable trends in the
history were relatively frequent palpitations (6–28% with
increased frequency in atypical/refractory and POTS
patients). By definition, there were fewer school absences in
those with typical low-severity or exertional syncope.
The family history was negative for cardiac disease in 1039
or 83% of all patients. Pertinent positives were noted in a
significant minority (Table 2). There were significantly lower
rates of a family history of sudden deaths for patients with
typical syncope compared to all other patients (Fisher’s
P=0.02) Otherwise, there were no significant differences
between those with typical and other than typical syncope.
At the time of the initial cardiology evaluation, 284 (23%)
had been seen by another specialist. Seventy-seven percent
Figure 1. Patients enrolled by syncope type. Distribution of
patients enrolled throughout the SCAMP by clinician-assigned
syncope type. POTS indicates postural tachycardia syndrome;
SCAMP, Standardized Clinical Assessment and Management Plan.
Table 1. Demographics by Syncope Type
Total Mild Typical >Mild Typical Atypical/Refractory Exertional Convulsive POTS
Age, y*
N 836 600 123 23 48 20 22
Mean (SD) 14.5 (3.0) 14.1 (3.1) 15.7 (2.2) 15.6 (2.4) 15.2 (1.9) 14.5 (2.8) 14.5 (2.4)
Sex*
N 836 600 123 23 48 20 22
Male, n (%) 313 237 (76) 24 (8) 13 (4) 16 (5) 11 (4) 12 (4)
Female, n (%) 523 363 (69) 99 (19) 10 (2) 32 (6) 9 (2) 10 (2)
BMI, kg/m2
N 1122 782 165 40 71 35 29
Mean (SD) 21.4 (4.4) 21.2 (4.4) 21.6 (4.2) 23.3 (4.0) 21.6 (4.0) 21.7 (5.5) 21.3 (4.0)
SSS
N 1249 870 188 43 77 39 32
Mean (SD) 2.5 (1.9) 1.8 (1.1) 5.3 (1.4) 4.3 (2.9) 2.1 (1.6) 2.9 (2.3) 5.1 (2.9)
BMI indicates body mass index; NECCA, New England Congenital Cardiology Association; POTS, postural tachycardia syndrome; SSS, Syncope Severity Score.
*Data-use agreements limited age and sex data from NECCA sites.
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of these patients were classified as having typical syncope.
Patients with atypical or convulsive syncope and POTS were
significantly more likely to have seen other specialists (40% to
60%). Exertional syncope patients were least likely to have
been referred to another specialist at 12% (overall P<0.01).
Overall, prior emergency room visits had occurred in 40% of
patients. Those with typical syncope were less likely to have
had prior emergency care (P<0.01).
A significant minority of patients (39%) reported medica-
tion use. Those with a SSS ≤4 had a lower proportion of
medication use than those with a higher score (35% versus
67%) with higher SSS strongly associated with increased
medication use (Odds Ratio: 1.395%, CI: 1.2–1.4 for each
1-point increase in syncope score P<0.0001) (Figure 2). When
stratifying by syncope type, patients with typical low-severity
syncope and exertional syncope had the lowest reported
medication use. This finding was most prominent with
psychiatric medications, though true for several other classes
of medication.
Syncope scores
There was the expected asymmetric distribution of syncope
scores, with 79% of patients reporting overall wellness scores
>7 (10 “perfect”), and 63% dizziness scores <3 (10 “falling
down/dizzy every time I stand”). Physician-assigned score
was similarly <3 in 58% indicating minimal severity. Patients
with atypical syncope and POTS had higher dizziness scores,
lower overall wellness scores, and higher physician-assigned
scores. Graphically, the distribution for each of the scores
overlapped as expected. In each comparison, there were a
small number of “mismatches” with better or worse perceived
severity than the SSS suggested. This pattern was seen with
each of the paired comparisons (Figure 3).
Physical Exam Findings
Ninety-three percent of patients had a normal exam result.
Joint hypermobility was noted in 1% with a mix of other less
specific abnormalities in 3.4% and incomplete data forms in
13%. Pathologic murmurs were rare, noted in <1%. There was
no significant difference between groups (v2 P=0.70).
Table 2. Patient and Family History Characteristics
Characteristic n (%)
Patient history
Patient experienced prodrome? 1080 (89)
Dizziness or light headedness? 1060 (86)
Syncope with rest? 944 (76)
Symptoms resulted in a syncopal event?* 521 (76)
Visual change? 853 (70)
Patient experienced color change?* 604 (60)
Patient experienced loss of tone?* 661 (59)
Anxiety? 276 (23)
Patient incurred injury during the event? 215 (17)
Syncope postexercise? 179 (14)
Palpitations? 129 (11)
Absences from school? 148 (12)
Patient had convulsive-like activity? 107 (9)
Syncope with exercise? 106 (9)
Palpitations unrelated to prodrome? 98 (8)
Patient experienced incontinence? 35 (3)
Was there any level of disability with the event? 78 (7)
History of recurrent joint dislocation? 22 (2)
Family history
Frequent fainting (first-degree only)? 199 (17)
Arrhythmia/pacemaker/ICD? 116 (10)
Congenital heart disease? 68 (6)
Cardiomyopathy? 30 (3)
Sudden unexplained death (<50 years)? 30 (2)
Heart failure (<50 years)? 17 (1)
Individual patients could report multiple history findings. The presence of color change
and loss of tone resulted in unknown or missing responses in >10% of SDFs. One
question “Did the patient experience a syncopal event?” was not answered by 46% of
respondents and was judged unreliable. ICD, implantable cardioverter defibrillator; SDFs,
SCAMP Data Forms.
*≥10% missing.
Figure 2. Medication use by syncope severity. Bar graph of
medication use is stratified by syncope severity. The majority of
patients with typical low-severity syncope and exertional syncope
were not on any medications, with 33% of typical low-severity
patients on a wide range of medications, none with a frequency
>10%. More symptomatic patients were frequently on medications,
with that finding most apparent for psychiatric medications, and
statistically significant with several other medication classes.
Increased Syncope Severity Score (SSS) was strongly associated
with increased medication use (odds ratio: 1.3, 95% CI 1.223–1.4,
per 1-point increase in syncope score, P<0.0001). GI indicates
gastrointestinal; OCP, oral contraceptive.
DOI: 10.1161/JAHA.115.002931 Journal of the American Heart Association 5
















The Phase 1 pathway recommended sitting heart rate and
blood pressure with formal orthostatic vital signs using the
American Autonomic Society guidelines of supine values at 1
and 3 minutes followed by standing values at 1 and
3 minutes.16 Each specific value was recorded in 40% to
76% of patients with typical syncope and in 75% to 94% of
patients diagnosed with POTS. For the initial SDF, a change in
HR between supine and standing of ≥30 bpm combined with
plausible symptoms permitted a diagnosis of POTS.
For the overall cohort, the baseline supine HR was 7313
with blood pressure of 111/60 (11 mm Hg for systolic
blood pressure [SBP] and 9 for diastolic blood pressure
[DBP]). There was no clinically meaningful change between
the 2 supine measurements. There was a mean 22 (14) bpm
increase in HR by 3 minutes of standing (P<0.0001). SBP did
not change with standing, while DBP increased a mean of
5 mm Hg (95% CI 3.9–5.8, P<0.0001).
Supine SBP and DBP were statistically slightly lower
compared to sitting (SBP 11112; DPB 639, P<0.01) but
the magnitude of that change was sufficiently small (95% CI
0.4–2.1 mm Hg for SBP and 2.0–3.5 for DBP) that these
distinctions were judged insignificant in a practical sense.
With continued standing between the first and third minutes,
there were minimal changes in paired systolic BP measure-
ments (an 2 mm Hg decline between 1 and 3 minutes) with
no change in mean measurements.
A summary of orthostatic HR changes is presented in
Figure 4. Overall, 79% of typical syncope patients had
<30 bpm and 94% had <40 bpm increase from supine heart
rate at 1 minute to standing heart rate at 3 minutes
compared to 36% of patients classified as POTS who had
<30 bpm and 64% <40 bpm increase, respectively.
The relationship between orthostatic changes and clinical
classification of POTS was examined with a series of receiver
operating characteristic curves. This analysis supported using
the difference between standing 3 minutes and any of the
supine measures (1 minute, 3 minutes, or the minimum) as
most predictive of this clinical classification, albeit with an
only modest precision evidenced by an area under the
receiver operating characteristic curve of 0.76 to 0.79.
Receiver operating characteristic analyses for SBP and DBP
showed no ability to discriminate.
ECG Testing
There was high adherence to obtaining an ECG, with 98% of
those presenting reporting results. Overall 90% were normal.
Figure 3. Weighted circle plot of correlating combinations of the
2 different symptomatic scores. The size of the circle reflects the
number of responses. This example demonstrated the 0 to 10
dizziness/syncope score compared to the 12-point ad-hoc physi-
cian-assigned scores. The pattern was similar for each pairing. All
had strong clustering at the “well” end of the scale. Each score had
patients who had mismatches between the different scales.
Figure 4. Cumulative histograms of absolute heart rate (A) and
change in heart rate between 3 minutes of standing and the initial
supine heart rate (B). For typical syncope, the 90th percentile of
standing heart rate was 115 bpm with the 93rd percentile at 120.
Similarly, for the change in heart rate 35 bpm represented the 90th
percentile. For comparison, those classified as postural orthostatic
tachycardia had a wide range, though a reasonable percentage
were well within the normal changes. HR indicates heart rate;
POTS, postural tachycardia syndrome.
DOI: 10.1161/JAHA.115.002931 Journal of the American Heart Association 6















ECGs were intended to be evaluated using criteria that
mirror the Seattle Criteria17 included on the SDF. A detailed
listing of abnormalities in typical syncope (Table 3) revealed
multiple “borderline” findings. Those findings were a minor
contributor to use of echocardiograms. Proportionally more
ECGs were reported to be abnormal (16%, 21%) in the relatively
small number of patients presenting with exertional and
atypical/refractory syncope (Fisher Exact P<0.0001). Border-
line QTc intervals (7) and an ECG with a putative Brugada
pattern were identified that would appropriately require addi-
tional evaluation in 0.6% of the ECGs. By design, those with
diagnostic findings of WPW and QTc >480 ms were excluded
from the SCAMP.
Ambulatory Monitoring
One hundred and twenty-four patients underwent ambulatory
monitoring. Only 62 results were reported, with 87% of these
reported as normal and 8 (13%) with incidental findings. No
results explained the syncope.
Echocardiogram Findings
Echocardiograms were performed in 331 patients (26%),
with indications for echocardiograms summarized in
Table 4. Indications were not recorded in 14%. A single
patient in the exertional group was found to have cardiac
syncope, with hypertrophic cardiomyopathy. A post-hoc
analysis was done based on the reported findings, syncope
classification, and comments. Including that analysis, 85%
of the echocardiograms performed were done in compliance
with the SCAMP protocol, and 5% were performed for
family or primary care physician anxiety. The vast majority
(226, 88%) were normal with scattered incidental findings
seen in 11% (Table 5). With the single exception, none of
those findings were felt to explain the syncope. They
ranged from completely trivial to findings that may drive
additional follow-up. Data were not collected on the clinical
response to these findings.
Ferritin levels and laboratory testing
There was low compliance with this recommendation. Of
the 188 patients with typical syncope scaled as moderate
to severe, 71 (38%) had no lab work obtained with only 54
(29%) having both complete blood count and a ferritin level
as recommended. Overall 94 (8% of total) had ferritin levels
obtained. Of the 14 patients with mild typical neurally
mediated syncope and ferritin lab results, 6 (43%) had
ferritin <50 ng/mL, suggesting low iron body stores. No
follow-up was available after intervention with iron supple-
mentation.
Follow-Up
There were a total of 143 follow-up encounters represent-
ing 10% of the total visits. One hundred and one (71%) of
these encounters were follow-up for typical syncope.
Deviations in practice and patient behavior were instructive.
While 127/843 (15%) of patients with a low-severity typical
syncope score were recommended for follow-up, only 34
(4%) returned. Overall, cumulative follow-up rates were
higher for the 379 patients with other syncope types.
Largely because typical low-severity syncope is so common,




Bundle branch block 12 (13)
RVH 11 (11)
Inverted T-waves 9 (9)
QRS axis <20 and >130 7 (7)
QTc 450 to 479 ms 7 (7)
RAE or LAE 3 (3)
Ventricular ectopy 3 (3)
ST-T segment change >2 mm 2 (2)
PR interval >220 ms 2 (2)
Atrial ectopy 2 (2)
Brugada pattern 1 (1)
Other abnormality 39 (41)
Sinus bradycardia 10
Nonspecific ST-T wave changes 7
Right axis deviation 4
Left axis deviation 3
First-degree AV block 3
Atrial premature beats 2
Borderline LVH 2
Flattened T waves—low voltage 1
Sinus arrhythmia 1
Sinus rhythm with RSR prime, not meeting RVH criteria 1
Pathologic Q waves, decreased RV side forces 1
RSR prime pattern in V1 and V4R consistent with
right ventricular hypertrophy
1
Borderline RAE, want f/u ECG 1
Pure R in V1 1
RSR’ c/w right ventricular volume overload 1
AV indicates atrioventricular; c/w, consistent with; f/u, follow-up; LAE, left atrial
enlargement; LVH, left ventricular hypertrophy; RAE, right atrial enlargement; RVH, right
ventricular hypertrophy.
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89 (62%) of the follow-up encounters that occurred were for
SSS ≤4.
Adherence to Initial Guidelines
The pathway flow charts were analyzed to create deviation
reports. We focused on the typical syncope. Overall adher-
ence was excellent, with >90% adherence for initial evaluation
and most specific decision points. Notable findings included
the lack of clarity in 3 of the history questions with one
question eliminated from analysis.
Overall testing deviation is summarized in Table 6. For
typical low-severity syncope, the most frequent deviation was
the choice to obtain an echocardiogram. Only in a minority of
encounters were echoes not obtained when recommended.
This practice persisted for echo for other types and severity of
syncope. For other cardiac testing (Exercise, Ambulatory ECG)
the frequency of deviations was lower, while for lab testing
the frequency of deviations was higher. There were signifi-
cantly more deviations in those encounters with syncope that
was not typical, low-severity syncope (P=0.02 for echo,
P<0.01 for exercise test, ambulatory ECG, and lab testing). Of
patients with deviations, there were significantly more
deviations to obtain a nonrecommended test in typical low-
severity syncope compared to other syncope classifications.
In other classifications, the deviations were more frequently
to defer testing (P<0.01 in all 3 cases). There was some
variability in the use of orthostatic vital signs, with less
frequent completion of those in patients with typical low-
severity syncope. Additionally, as noted above, follow-up
recommendations varied both in clinician and in patient
acceptance. Taken together, that behavior suggested less
follow-up was required.
An abnormal ECG was intended to trigger an echocardio-
gram; however, in 35% of those cases an echocardiogram was
not ordered, further emphasizing the marginal perceived utility
of echocardiography and/or of borderline ECG findings.
Discussion
During the first 2 years of a regional SCAMP implementation
focusing on childhood and adolescent syncope, 85% of the
patients enrolled were diagnosed with typical syncope. This
cohort had the expected demographics with an average age of
14.5 years and the majority of patients female.4 Typical
syncope was by far the most common diagnosis for both
sexes. There was a trend toward a higher frequency of males
with convulsive syncope and females with exertional syncope.
Typical neurally mediated syncope had the expected historical
features although potentially high-risk characteristics such as
injury, incontinence, and syncope around exertion occurred at
moderate frequency without obvious heart disease.
This study documents the largest systematic use of
orthostatic vital signs for the evaluation of syncope in
pediatric patients. Noteworthy is the large variability in
orthostatic HR response in patients with typical syncope
(20% demonstrated >30 bpm increase in HR by 3 minutes
and 7% a 40 bpm increase). Our findings confirm the recent
shift to requiring higher cutoff values of >40 bpm in pediatric
and adolescent patients to make a diagnosis of POTS.16,18 An
important practical new finding is the observation that
orthostatic blood pressure changes between supine, sitting,
and standing were clinically trivial in all syncope groups and
therefore deemed not useful in this setting. We propose a
streamlined workflow for initial visits that includes a single
seated HR and blood pressure. For those where the possibility
of POTS is being considered, use of supine and 3-minute
standing HR measurements (without obtaining blood pres-
sure) is reasonable with a cutoff of a 40 bpm increase and a
standing HR of >115 to 120 at 3 minutes distinguishing a
normal versus exaggerated response to orthostatic pulse in
an office setting.
This SCAMP used 3 simple syncope severity scores.
Patient-assigned subjective scores on dizziness and well-
being, modeled after Rowe’s early experience with POTS and



















Total 117 (35) 16 (5) 75 (23) 30 (9) 17 (5) 82 (25) 46 331
Mild typical 21 (12) 10 (6) 57 (32) 20 (11) 7 (4) 50 (28) 31 176
>Mild typical 5 (15) 2 (6) 3 (9) 3 (9) 4 (12) 10 (30) 10 33
Atypical/refractory 20 (69) 1 (3) 7 (24) 3 (10) 3 (10) 11 (38) 29
Exertional 61 (88) 2 (3) 5 (7) 1 (1) 1 (1) 4 (6) 3 69
Convulsive 9 (50) 2 (11) 2 (11) 2 (11) 5 (28) 1 18
POTS 1 (17) 1 (17) 1 (17) 1 (17) 2 (33) 1 6
PMD indicates primary medical doctor; POTS, postural tachycardia syndrome.
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Chronic Fatigue,19 generally correlated well with an ad-hoc
physician-assigned 12-point scale. The clinician behavior and
patient follow-up choices supported a physician-assigned
score of ≤4 representing low-severity syncope. Practically,
this designation included up to 2 to 3 episodes of syncope
with minimal school loss, no injury, and no late residual
symptoms. This physician-assigned SSS correlated with the
self-assigned scores for well-being and dizziness. These data
support using simple scores to help assess the level of
disability (whether perceived or absolute) for their syncope
symptoms. The SSS summarizes the actual and perceived
disability related to the syncope syndrome and likely will help
predict which patients may be interested in therapy or follow-
up. Importantly, because of the exceptionally low frequency of
identified cardiac disease, these scores do not affect prob-
ability of critical cardiac diagnoses. The 12-point SSS requires
some modification to effectively reflect follow-up visits, as the
number of faints was not limited to a defined time period.
There are ample data to support that typical neurally
mediated syncope in the school-age child and adolescent
results in excessive testing,20–22 with a systematic trend
toward more testing in the last 40 years.4 Adult groups have
developed reasonable predictive rules; however, they also
have disease incidence and severity that are orders of
magnitude higher than seen in pediatrics.23 Given the low
prior probability of significant disease, once the ECG is nearly
normal, serious cardiac disorders will always be rare in
pediatrics.24,25 Using SCAMP methodology, we can therefore
decrease practice variation and focus toward both an efficient
and a safe approach.
The ECG was asserted to have a high negative predictive
value for serious heart disease24 with early exclusion of
patients with WPW and Long QT Syndrome (defined as QTc
≥480 ms). Using predefined criteria, 10% of the ECGs
demonstrated a wide range of “borderline” abnormalities
not likely contributing to syncope. An abnormal ECG was a
minor contributor to the decision to perform an echocar-
diogram. The one new cardiac diagnosis had both high-risk
symptoms and a clearly abnormal ECG with T-wave
inversion and left ventricular hypertrophy. Interestingly,
16% of ECGs in patients with exertional symptoms were
read as abnormal. These may be systematic changes in
athletes’ ECGs, but could also suggest that cardiologists
may interpret the ECG differently when evaluating a patient
with a potentially higher probability of significant disease.
Neither bias would change practice, as history drives the
decision to obtain an echocardiogram or other testing in
those with exertional syncope.
The exclusion of WPW and LQTS, 2 of the most obvious
ECG diagnoses, represents the reality that in clinical evalu-
ation of a patient, any of those findings will drive decision
making away from typical syncope. A small number (7
borderline QTc and 1 potential Brugada pattern or 0.6%) of the
ECGs suggested additional investigations for ion channel
disorders. The overall prevalence of those disorders (1/700
for WPW and 1/2000 for LQTS) informs choices about
whether an ECG is “mandatory” following an event that
otherwise meets clinical criteria for typical, low-severity,
neurocardiogenic syncope.





Borderline MVP, no MR
Tricuspid valve prolapse




Borderline apical LV noncompaction
Coronary arises from ST junctional, normal courses (??)
Trivial AI, normal aortic valve
Secundum atrial septal defect
Mild aortic regurgitation and likely partial fusion of his aortic
valve commissure
Small fenestration in the atrial septum with left-to-right
flow
Moderate TR and tiny patent foramen ovale
Mildly dilated LV, low normal function
Bicuspid aortic valve (mild aortic insufficiency, no aortic
stenosis). No root dilation.
Mild central aortic regurgitation and mild descending aortic
dilation
Mild LV dilation
Normal structure, but some ectopy




Mild pulmonary branch stenosis
Exertional High takeoff of right coronary
Top normal to mild root dilation
Trivial aortic regurgitation
Possible small patent foramen ovale
Aortic insufficiency
Partial fusion of L & R coronary cusp
Mildly dilated left ventricle, normal mass:volume ratio
Small ASD
Small left coronary system of concern, but not definitive
AI indicates aortic insufficiency; ASD, atrial septal defect; LV, left ventricular; MR, mitral
insufficiency; MVP, mitral valve prolapse.
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The vast majority (85%) of echocardiographic studies
were performed for historical details or other clear SCAMP
indications. The most common indication for echo was the
description of the syncopal event in 35% of patients. Echo
was performed less frequently in those with typical
syncope, only 20% compared to 64% of those with other
than typical syncope. Given the larger volume of patients
with typical syncope, these represented 63% of the echoes
performed. Similar to the chest pain SCAMP,7 incidental
echocardiogram findings that did not explain the syncope
were identified in 11%.7 The high frequency of deviations
from the proposed guidelines emphasizes the variations in
perceived marginal utility of echo. The need for a post-hoc
analysis to review echo indications demonstrated limitations
in both the SDF and likely the nature of decision making.
Interestingly, during the chest pain SCAMP 40% of
patients had echocardiograms.7 While echo use did not
decline over the period of use of the syncope SCAMP, the
overall use of echocardiography was nearly half that of the
chest pain SCAMP, which immediately preceded this effort
and included substantial overlap among practitioners. Even
in the peri-exertional syncope group, there was some
deviation away from doing an echocardiogram. While
speculative, it is plausible that the experience and comfort
with deferring an echocardiogram in the chest pain cohort
contributed to this behavior. Overall this may be part of
increased recognition that all testing has the potential to
identify incidental findings,26 which may increase anxiety or
even morbidity.
There remains substantial practice variation in the use of
exercise testing and ambulatory ECG monitoring. Both have
significant limitations as diagnostic tests and carry with them
important logistical concerns that increase the burden on
families/physicians. Given the low yield of either in identifying
serious disease, future efforts will aim at much more selective
use of these studies.
While the follow-up volume and duration was somewhat
limited, these data showed that fewer people were recom-
mended to return than suggested on the initial guideline and
that fewer still actually returned for follow-up. This behavior,
quite likely, represents the appropriate follow-up and suggests
that a reassuring “come back if you have more problems”
approach is fully justified.
The low incidence of identified cardiac disease, combined
with Kane’s retrospective analysis demonstrating the effec-
tiveness of identifying life-threatening cardiac disease using
the chest pain clinical pathway,10 emphasize that clinicians
are quite effective at identifying those disorders. Hence, when
patients return with problematic symptoms, and without a
specific feature of the history suggesting serious disease, the
focus may be more on effective management of the
symptoms. Fortunately, as the vast majority of patients do
not need to return, even this large experience cannot provide
useful data on more advanced and pharmacologic manage-
ment.
Two related observations raise the question of whether
patients with high syncope scores and more disability
(atypical, POTS, and high-severity typical syncope) represent






% With Test Against
Recommendation
% Without Test Despite
Recommendation
Overall
Echo 1228 20 16 4
Exercise test 1209 10 3 7
Ambulatory ECG 1214 9 6 4
Ferritin Lab 1254 13 2 11
Mild typical
Echo 861 18 14 4
Exercise test 875 2 2 0
Ambulatory ECG 875 5 5 0
Ferritin Lab 875 2 2 0
All others
Echo 367 23 20 3
Exercise test 334 30 4 26
Ambulatory ECG 339 21 8 13
Ferritin Lab 379 41 3 38
DOI: 10.1161/JAHA.115.002931 Journal of the American Heart Association 10















a comprehensive pediatric “problem” more than a subspe-
cialty cardiology problem. These subgroups had high use of
prior specialty referrals and a high use of medications. There
are at least 3 potential causes for that association, which
cannot be answered here. These patients may have a medical
or psychiatric diagnosis that makes them more prone to
syncope; their therapy may predispose them to syncope
(certainly a common cause of syncope in the elderly), and
lastly, they may be excessively medicalized with syncope part
of a pattern of somatization. All of those potential causes
suggest careful evaluation of problematic patients in their
medical home prior to or coincident with referral to
cardiology.
The Boston Children’s Hospital emergency department, in
parallel with these efforts, demonstrated that a systematic
approach to syncope patients can decrease resource utiliza-
tion and limit low-yield testing.27 A multicenter experience in
China included a relatively large number with cardiac
syncope.28 With a tiered protocol that included frequent
head-up tilt testing, typical syncope was identified in 73% of
patients. They assert that this approach decreased resource
utilization, even if they were more interventional than current
local practice. The guideline used here specifically accepts
that typical low-to-moderate-severity syncope is almost
certainly neurocardiogenic, and does not require confirmatory
testing. That choice was made both because head-up tilt
testing is increasingly discredited as a routine test for typical
syncope29 and to limit the medical burden associated with
physiology that overlaps with normal.30 This workflow permits
some uncertainty regarding the precise noncardiac diagnosis,
with the trade-off of limiting patient, family, and medical
resource use. Implicit in that overarching plan is that more
complicated pictures (whether POTS, somatoform, or difficult-
to-identify arrhythmias) will have recurrent symptoms and can
return for care.
Limitations
Serious cardiac disorders both are likely identified immedi-
ately and may present less frequently in the office setting. By
design, WPW and Long QT Syndrome, the 2 diagnoses most
apparent on ECG, were excluded from the SCAMP. Clinicians
chose to enroll patients in this process, so that if they
immediately classified them as having heart disease the
patients are not included in this experience. This initial report
focuses on the majority with typical syncope and cannot
provide significant data on the more problematic patients with
either other forms of syncope or those who had follow-up
recommended or chose to return for follow-up.
Explicit in an approach like this is that there will always be
rare diseases that either are not seen on ECG or exam
(anomalous coronary, catecholaminergic polymorphic VT as 2
classic examples). Both are rare, both are classically associ-
ated with at least peri-exertional if not midexertional symp-
toms,31,32 and hence, in this clinical pathway, should be
detected with proscribed testing. All diagnostic testing carries
with it the risk of incidental findings, false positive/false
negative results, and ineffective interpretation (whether a
technical or provider issue). While these data incompletely
tabulate the burden of “positive” tests, they do not address
those issues. Test results are not adjudicated or confirmed.
Rather, the SCAMPS approach focuses on the behavior of the
clinician in reacting to the data.
During pathway development, we invested significant
energy in suggesting more advanced therapy options and
somewhat creative approaches to advanced testing. The
paucity of patients with more persistent symptoms limited
further analysis. The limited data on ferritin levels support the
idea that considering deficient iron stores may be a contrib-
utor to more symptomatic patients.13,14 The poor adherence
to those recommendations similarly suggested (at least to the
cardiologists) that iron studies are best done in a primary care
setting. The enthusiasm for developing these more advanced
options speaks to the challenge of treating patients with
higher SSS despite representing a small group.
Experienced clinicians rapidly identify precise details of the
history that shift their thinking toward more serious diag-
noses.5,32,33 Given the low incidence of serious disease, this
experience has a limited role in refining that algorithm. The
frequency of palpitations, injury, and incontinence seen only
emphasizes that those findings have a limited positive
predictive value.
Conclusions
Using SCAMP methodology, we have demonstrated that
typical neurally mediated syncope represents the vast major-
ity of children referred to pediatric cardiologists for syncope.
Cardiac etiology is rare, and in this study one patient with
hypertrophic cardiomyopathy was identified using the sug-
gested evaluation plan. Syncope can be evaluated in the
ambulatory setting pragmatically and effectively using mini-
mal resources and in the vast majority in a single initial visit.
This experience confirms and solidifies many of the
traditional historical details that define typical neurally
mediated syncope. Subjective and physician-assigned Syn-
cope Severity Scores appear to provide a rapid way to stratify
patients likely to require additional care. The relatively high
frequency of potentially concerning family history, mild
abnormalities on ECG, and incidental findings on echocardio-
graphy and ambulatory monitoring serve as a cautionary note
regarding the need to place both the decision to obtain a test,
and its interpretation in context.
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Finally, our findings demonstrate that orthostatic vital
signs add little if anything to the initial evaluation. Those
should be reserved for more symptomatic patients in whom a
streamlined workflow with a single baseline blood pressure
followed by use of supine and 3-minute standing HR
measurements is appropriate. Using that technique, a stand-
ing HR <120 bpm and a change from supine to standing of
<40 bpm is within the 93rd percentile, and <115 bpm and HR
change of <35 bpm is within the 90th percentile. Those
ranges provide data-driven and easy-to-remember thresholds
for those in whom orthostatic intolerance is the more likely
contributor to daily symptoms.
Evolving and explicit clinical pathways such as SCAMPS
can be implemented regionally across a wide range of clinical
practice settings, and this approach can overcome a number
of barriers often limiting traditional clinical guideline imple-
mentation and prospective randomized controlled trials. They
represent a way to relatively rapidly gain and disseminate
experience among providers and centers.
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